RECRUITING

A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Future Self-BD is a 6-session virtual intervention that encourages participants to vividly generate personal and positive future events that they anticipate may be benefited by smoking cessation. Each session will be conducted on HIPAA-compliant Zoom and led by the PI (Dr. Gold).

Official Title

Future Self: an Episodic Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder

Quick Facts

Study Start:2024-11-18
Study Completion:2028-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06609902

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults aged 18 or older
  2. * Have a diagnosis of BD I or II
  3. * Have a diagnosis of tobacco use disorder
  4. * Be engaged in outpatient treatment with a medical provider
  5. * Be on a stable dose of a mood-stabilizing medication
  6. * Smoke an average of at least 5 cigarettes per day for the past 30 days at baseline (based on the Heaviness of Smoking Index(Heatherton et al., 1989))
  7. * Be interested in quitting smoking
  8. * Not currently or in the past 3 months be receiving smoking cessation treatment.
  1. * Current psychosis
  2. * Intent to harm oneself with an associated plan and intent to act on suicidal thoughts
  3. * Experiencing severe symptoms of depression and/or hypomania that may warrant a higher level of care (a Patient Health Questionnaire-9 total score ≥ 20(Kroenke et al., 2001) and/or an Altman Self-Rating Mania Scale total score ≥ 6(Altman et al., 1997) will trigger further clinician evaluation)

Contacts and Locations

Study Contact

Yousif Alsaadi, B.S.
CONTACT
6177260997
yalsaadi@mgb.org

Principal Investigator

Alexandra K Gold, PhD
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital

Study Locations (Sites)

Massachusetts General Hospital
Boston, Massachusetts, 02114
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

  • Alexandra K Gold, PhD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-18
Study Completion Date2028-10

Study Record Updates

Study Start Date2024-11-18
Study Completion Date2028-10

Terms related to this study

Keywords Provided by Researchers

  • bipolar disorder
  • comorbid tobacco use disorder
  • smoking cessation

Additional Relevant MeSH Terms

  • Bipolar Disorder
  • Tobacco Use Disorder